ArticleFrontiers in endocrinology2023

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Rasmus Stenlid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.